.: The Head and Neck Cancer Program at The Leon Hess Cancer Center :.

The Head and Neck Cancer Program at
The Leon Hess Cancer Center

The American Cancer Society estimates that more than 60,000 Americans are diagnosed each year with head and neck cancers of the oral cavity, including salivary gland, tongue and mouth, and pharynx, respiratory system, including larynx, and endocrine system, including thyroid.

In the News

Monmouth Medical Center Joins Prestigious Clinical Trial Focusing on Head and Neck Cancers
[ More ]

At Monmouth Medical Center, otolaryngological (Ear, Nose and Throat, or ENT) surgeons are treating a host of head and neck cancers through a multidisciplinary team approach in a caring and supportive environment that supports prompt and effective care. The program also provides services that help patients and their families adapt to living with a cancer diagnosis.

Through Monmouth's Leon Hess Cancer Center, Head and Neck Cancer Program medical director Darsit Shah, M.D., and assistant medical director Arvind Prabhat, M.D. - otolaryngologists with special expertise in complex head and neck surgical procedures - lead a team comprising ear, nose and throat and plastic surgeons, medical and radiation oncologists, internists, endocrinologists, dentists pathologists, radiologists, clinical nurse, data/research nurse, psychosocial specialist, nutritionists and speech pathologists. Monthly multidisciplinary team meetings are held where cases are reviewed and treatment options are discussed.

Monmouth Medical Center
300 Second Avenue
Long Branch, New Jersey 07740
PHONE: (732) 222-5200
info@sbhcs.com
©1998 Saint Barnabas Health Care System

Vin Prabhat, M.D.
Otolaryngology / Head and Neck Surgery
Monmouth Medical Center
Vin Prabhat, M.D., received his medical degree from Cornell University Medical College. After completing a residency in otolaryngology head and neck surgery at Mount Sinai Medical Center, he went on to complete a fellowship at the American Academy of Facial Plastic and Reconstructive Surgery.
An attending surgeon at Monmouth, Dr. Prabhat is board certified in otolaryngology and facial plastic and reconstructive surgery. He has done research in these fields as well as in the area of oncology.
A Fellow of the American College of Surgeons, his professional affiliations include the American Academy of Otolaryngology Head and Neck Surgery and the American Academy of Facial Plastic and Reconstructive Surgery. He has delivered several presentations concerning his field of expertise.

Darsit K. Shah, M.D.
Medical Director
Head and Neck Cancer Program
Darsit K. Shah, M.D., received his medical degree from the Medical College of Pennsylvania and completed his residency in otolaryngology at Mount Sinai Hospital. He went on to complete a fellowship in neurotology at the Michigan Ear Institute. Board certified in otolaryngology, Dr. Shah is now an attending surgeon at Monmouth. He was inducted into the Junior Fellow American Neurotologic Society, and is a member of the Academy of Otolaryngology Head and Neck Surgery.

Among his special honors and achievements, Dr. Shah is a member of the Alpha Omega Alpha honor society and received the McGraw-Hill Award. He has completed several papers, presentations and publications on many surgical procedures.

Dr. Mitchell Weiss
Chairman, Radiation Oncology

Mitchell Weiss, M.D., received his bachelor of science degree in chemistry from the University of Illinois, Urbana, Il where he graduated phi beta kappa and was a golden key national honor society member. He received his medical degree from the University of Chicago Medical School, Pritzker School of Medicine.
Dr. Weiss completed his residency in radiation oncology at Memorial Sloan-Kettering Cancer Center, New York, serving as its chief resident in 2002-2003. During residency, Dr. Weiss was involved in research activities including head and neck as well as gynecologic malignancies. Dr. Weiss has presented his work at national meetings including the American Society for Therapeutic Radiology and Oncology and the American Society of Clinical Oncology.
He is board certified in radiation oncology, and his professional affiliations include the American Society for Therapeutic Radiology and Oncology, the American Society of Clinical Oncology, the American Brachytherapy Society, and the New York Roentgen Society.

Dr. David J. Sharon
Medical Director
The Leon Hess Cancer Center

Medical oncologist David J. Sharon, M.D. received his medical degree from New York Medical College, New York, and completed a four-year residency in internal medicine at Beth Israel Medical Center, New York. He completed a fellowship in neoplastic disease at Mount Sinai Medical Center in New York, where he served as chief clinical fellow. He has served as section chief for hematology/oncology at Monmouth since 1985 and is a past president of the hospital's Medical and Dental Staff.
He is a diplomate of the American Board of Medical Oncology and among the professional organizations he holds membership in is the American Society of Clinical Oncology. Dr. Sharon recently was named co-chair of the Task Force on Cancer and Aging by the New Jersey Commission on Cancer Research, and he is the co-chair of the Lung Cancer Committee of The Cancer Institute of New Jersey's Cooperative Group.

Dr. Sang Sim
Radiation Oncologist
The Head and Neck Cancer Program

Sang Sim, M.D., received his bachelor of arts degree from Rutgers College where he graduated in the top 1% of his class. He graduated from University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School where he was elected to early induction into Alpha Omega Alpha, a prestigious national medical honor society. He graduated at the top of his class and was among the first to receive the Stanley S Bergen Medal of Excellence.

Dr. Sim completed an internship in internal medicine at Robert Wood Johnson University Hospital/St. Peter’s University Hospital where he was elected “Outstanding Resident of the Year”. He completed his residency in radiation oncology at Memorial Sloan-Kettering Cancer Center, New York, serving as chief resident. During his time spent there, he performed duties as acting brachytherapy fellow specializing in the use of permanent and temporary seed implants in the treatment of various malignancies including prostate cancer. In addition, Dr. Sim brings expertise in the use of intensity modulated radiation therapy and stereotactic radiosurgery.
Dr. Sim has interests in research and has published on lung and prostate cancer. He is board certified in radiation oncology, and his professional affiliations include the American Society for Therapeutic Radiology and Oncology